About Resources Disclaimer rd (at) patentbusinesslawyer (dot) com
China · Office-action response

China Patent Office Action Response: CNIPA Deadlines and 2026 Rules

Responding to a CNIPA examination opinion? Identify the actual notice and whether priority examination was granted before calculating the reply period or changing the Chinese claims.

Save or follow this source
China patent filing and examination planning
China patent decision guideCNIPA notice · 2026 priority rules · claim arguments

How should a CNIPA patent examination opinion be answered?

The page keeps ordinary examination, priority examination, novelty and inventive-step objections separate, especially under the September 2026 priority-examination rules.

Direct answer: An effective CNIPA reply addresses the precise examiner findings, supporting disclosure and applicable deadline. The one-month response period under CNIPA Order 85 applies to invention applications accepted into the priority-examination track; it is not a universal deadline for ordinary examination.

Direct answer: how a CNIPA reply is prepared

First or subsequent examination opinion

A CNIPA examination response begins with the specific official notice in the Chinese application file. Identify the notice type, issued date, authorized local representative, claimed invention, examiner's objections, cited references and designated response period. The examiner may raise novelty, inventiveness, clarity, support, sufficiency or other questions, and each requires issue-specific analysis. An English-language summary is useful to an international client but should never replace review of the actual Chinese-language record.

Priority examination and non-equivalent notice types

The page's working answer is a response plan: map the examiner's conclusions to current claims, decide which propositions should be contested, evaluate amendment support and obtain local counsel approval before filing. Do not substitute a PCT written-opinion response for the national CNIPA reply, because timing and local statutory requirements may differ.

Official reference: Response periods explanation (2022 official response).

Identify the actual notice and track

Ordinary published response guidance

Chinese patent files can contain examination notices, procedural notifications and communications connected with an approved priority-examination route. Ordinary examination and prioritized handling must not be merged into a single “CNIPA deadline.” Read the heading and references of the actual document and trace any official approval of special treatment. In a multinational portfolio, the notice may be received by a local agent before the central team has reviewed it; record both issuance and the governing rule.

2026 priority examination and actual notice deadline

When a case has parallel invention and utility-model applications or related applications in the family, determine which application and claims the notice concerns. The proper response for one technical solution may not carry across automatically. A clean record should distinguish official requirements from attorney workflow recommendations and preserve the Chinese source text underlying each translated excerpt.

Response deadline under ordinary and priority examination

Separate ordinary from priority-examination deadlines

CNIPA's Priority Examination Measures (Order 85) took effect on 1 September 2026. For prioritized invention applications covered by those measures, the official rule gives a one-month response period from issuance of an examination-opinion notice; different shorter periods are set for certain utility-model or design communications. These special deadlines cannot be applied to an ordinary invention application merely because it concerns an important technology.

Verify the operative notice date and consequences

The rule also addresses circumstances in which priority treatment may be terminated, including failure to respond within the specified period or requesting an extension. Docketing should therefore show a clear “ordinary / priority” classification and supporting approval document. For ordinary examination, rely on the applicable rules and actual notice rather than a blanket statement of months borrowed from another jurisdiction.

The special one-month deadline is stated in Article 16 of CNIPA Order 85 (effective 1 September 2026); confirm the notice is in the approved priority-examination track.

2026 Examination Guidelines: what changed and what must be checked

Locate the applicable 2026 guideline changes

CNIPA amended its Patent Examination Guidelines with changes effective in 2026. Whether a provision affects a particular response depends on the notice date, claim category, subject matter and transition rule. Before invoking new guidelines, confirm the precise Chinese-language text, its effective date and whether the examiner's specific objection falls within its scope. A news summary about a revision is not the legal test.

Link each CNIPA objection to its governing provisions

For AI and software-related cases, distinguish the patent-eligibility inquiry from objections to how an algorithm is disclosed, which technical features are claimed and whether a claimed effect is adequately supported. For pharmaceuticals, materials and devices, the core evidence can be quite different. Avoid one-page assertions that the latest guidelines make an entire technology universally patentable or unpatentable.

Official reference: Amendments to Patent Examination Guidelines (Order 84).

Novelty, inventiveness and disclosure objections

Address the examiner’s specific prior-art argument

A novelty argument should map each claimed element to the cited reference and identify any missing or differently arranged element. An inventiveness argument needs to assess the technical problem, the claimed technical solution, the reference combination and the examiner's explanatory path. A written-disclosure objection requires a different matrix: what is claimed, what the originally filed specification describes and whether the skilled reader can perform the invention.

Test Chinese claim clarity and technical disclosure

Do not rely on a US obviousness paragraph or EPO inventive-step heading as a substitute for Chinese-law reasoning. A globally consistent technical explanation is useful, but applicable legal language and evidence must be prepared for the CNIPA record. Claims to computer-implemented functions should be connected to disclosed technical implementation rather than commercial aspirations alone.

Chinese claim amendment evidence package

Document support in the Chinese text as filed

Proposed Chinese amendments must be tested against the application as originally filed. Identify the Chinese-language passages supporting each new feature, check consistency between the claims and the specification, and review whether an attractive narrower term introduces ambiguity or changes technical meaning. Create a support chart that a reviewer can use to track every change to its exact original location.

Check claim translations and amendment consistency

International claim families can be deceptive: a limitation accepted in Europe may rely on a differently translated phrase, while the Chinese filing may have distinct wording. If the national text is the controlling disclosure, review it rather than treating the English PCT source as determinative. Include a second-column assessment of whether the proposed amendment preserves the product's commercial implementation.

Arguments, translation, representative review

Prepare the Chinese-language legal and technical reply

Prepare arguments in the language and form required by CNIPA with local representative oversight. The draft should distinguish the applicant's factual explanation of the technology from propositions of Chinese law, and should cite the relevant reference or original disclosure at the point where the contention is made. Align any parallel English client memorandum with the filed Chinese text; translations should be checked especially where one term describes a core technical limitation.

Review conflicting family statements before filing

Before sending instructions, obtain a reference-indexed objection chart, redline of proposed claims, specification-support evidence, proposed legal reasoning and an express approval of the final Chinese submission. This reduces the risk of a technically correct internal memorandum becoming a materially different local filing through translation or last-minute changes.

Official reference: Priority Examination Measures (Order 85).

Risk register and source update checks

Build the notice, claim and cited-document register

The leading risks are misclassifying a priority-examination notice, missing an issue in a multi-part report, submitting an unsupported amendment, or using an outdated examination standard. A final checklist should record the official issue date, procedural track, filing portal, local agent, claim version, cited documents, disclosure support and evidence of submitted response. Any uncertainty about the effect of the 2026 measures must be resolved from the official rule before publication of a categorical claim.

Flag uncertain deadlines and source-version changes

The commercial decision is whether an argument or supportable amendment can protect the inventive implementation in China without needlessly surrendering rights in other target jurisdictions. Document that decision independently of the expectation that a reply will necessarily secure a patent. The appropriate outcome is a traceable, timely and legally reviewed response package.

CNIPA notice and reply-track comparison

This synthesis is a practical case-review tool, not a substitute for the governing office notices or rules. It separates the evidence to collect from the decision that still requires professional judgment.

Track / objectionEvidenceResponse planning issue
Ordinary examinationActual examiner notice and applicable rulesUse case-specific period, not priority-track assumption
Priority examinationOfficial approval and Order 85For qualifying invention notices, one-month reply period
InventivenessCited references and technical reasoningAddress claimed technical features
AmendmentOriginal Chinese disclosure and claimsCheck support and translated terminology

Evidence and deadline verification checklist

The audit trail should connect each procedural decision to a dated primary-source record and named reviewer. These items are practical evidence requests, not a guarantee of filing acceptance, enforceability or grant.

  • Application identity: Application number, applicant and entitlement, inventor names and current correspondence authority
  • Chronology: Earliest valid priority, other claimed dates, notice or entry deadline and calculated basis
  • Technical material: Original claims and description, figures, amendments, prior art and any technical translation
  • Current office procedure: Official instructions, accepted portal, forms, applicable fees and proof of submission
  • Legal review: Applicable exceptions, country-specific practice, disclosure support, agent instructions and next deadline

Primary official sources and currency checks

Sources below are first-party procedural references. Fees, portal operations, implementing rules and examination policies can change. Verify the version governing the actual case and document effective-date transitions.

Related evidence, legal strategy and technology decisions

For original patent claims and citations, the related patent research services and open research reference material address different evidence needs. For enforceable rights, licensing and transactions, consult patent commercial strategy and patent practice guidance where appropriate.

Technology-intensive patents may require a separate assessment of United States technology-law issues or technology-company legal operations. Additional counsel research and insights provide professional context; for the actual filing route, return to this site’s parent procedural guidance. These resources complement but do not supersede the responsible patent office.

Featured insight

Patent strategy depends on verified China rules and meaningful claim scope.

The legal response period and available amendments depend on the actual CNIPA communication, examination track and Chinese-language disclosure.

Featured Work & Insights

Assess a CNIPA examination opinion and claims strategy

rd (at) patentbusinesslawyer (dot) com

Email Dr. Rahul Dev